ArticleJournal of neurosurgery. Case lessons2025
Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe authors present a rare case of subependymal giant cell astrocytoma (SEGA) in a patient without tuberous sclerosis complex (TSC) and report characteristics of similar cases in the literature via a systematic review. OBSERVATIONS: A healthy 16-year-old male presented with headache and papilledema and was found to have an intraventricular mass. The mass was resected, and pathological analysis revealed SEGA. The patient developed recurrence with hydrocephalus necessitating open resection followed by CSF diversion. Next-generation sequencing was performed on the tumor, which revealed a homozygous TSC2 mutation. Targeted mosaic variant testing was negative in peripheral blood, indicating an acquired, rather than inherited, mutation. This likely represents a single mutation that underwent gene conversion during early astrocyte division. The authors performed a systematic review of the literature and found 59 additional documented cases of SEGA without TSC. Compared with TSC-associated SEGAs, isolated SEGAs tend to occur in older children, have lower rates of gross-total resection and higher rates of recurrence, and are always solitary lesions. LESSONS: Patients without TSC may develop SEGA due to somatic mutations. Thus, SEGA should remain on the differential diagnosis for intraventricular masses. Resection and histopathological diagnosis are usually indicated, especially for those complicated by hydrocephalus. Prognosis is favorable for isolated SEGA. https://thejns.org/doi/10.3171/CASE2566.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.